(NASDAQ:ARGX) reported positive topline results from its Phase 3 ALKIVIA trial of VYVGART Hytrulo in adults with autoimmune ...

A centuries-old heart drug costing less than ten cents a day could help keep heart-failure patients out of the hospital. New ...

Men who ate more ultra-processed food had a 24% to 31% higher reported risk of prostate cancer than those who ate the least, ...

Wait times for potentially curative cancer surgery, which have been climbing steadily for more than a decade, have risen ...

Learn more about Quantinuum Inc.'s (QNT) stock grades for Estimate Revisions and determine whether this IT Services stock ...

Q2 loss widens as R&D ramps ahead of REGAL trial final analysis and possible GPS BLA; SLS009 AML data due in Q4.

Precision measurements of calcium atoms revealed an unexpected pattern that cannot be explained by the simplest atomic ...

Goldman raised its Capricor stake to 73%, or 1.58 million shares valued at $38 million. Capricor plans to amend Deramiocel's ...

The baseball season is in full swing. As a sports fan, baseball, a sport obsessed with statistics, is ground zero for a ...

AI may free academics from narrow specialization, creating space for broader interdisciplinary thinking, systemic perception, and philosophical questioning of relationships, assumptions, and unresolve ...

BloodPril announces U.S. availability of a once-daily capsule combining three amino acid forms in a 500 mg proprietary ...

Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients ...